These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4141672)

  • 1. [Proceedings: Basedow's disease in pregnancy and parturition].
    Momotani N; Harada T; Nishikawa Y; Ito K
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):416. PubMed ID: 4141672
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Basedow's disease in pregnancy with antithyroid drugs].
    Iino S; Iigatani K; Ban Y; Miyamoto M; Watanabe M
    Horumon To Rinsho; 1974 Feb; 22(2):251-62. PubMed ID: 4136016
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of Basedow's disease].
    Ishii J
    Nihon Naika Gakkai Zasshi; 1990 Jul; 79(7):868-72. PubMed ID: 1700042
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basedow's disease in the pregnant woman. Should thyroxine be added to synthetic antithyroid drugs?].
    Lutz P
    Nouv Presse Med; 1976 Oct; 5(32):2081. PubMed ID: 62341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proceedings: Effect of the volume of iodine uptake on recurrence of Basedow's disease: in patients with suppression of iodine uptake due to actions of antithyroid agents].
    Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):409. PubMed ID: 4141671
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proceedings: Effect of inorganic iodine on serum thyroxine concentration in Basedow's disease--in patients during treatment with antithyroid agents].
    Ikeda H; Imai Y; Uchimura H; Matsuzaki F; Nagataki S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):408. PubMed ID: 4141670
    [No Abstract]   [Full Text] [Related]  

  • 7. [Basedow's disease and pregnancy].
    Luton JP; Guilhaume B
    Rev Prat; 1990 May; 40(15):1396-7. PubMed ID: 1694038
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proceedings: Recovery rate in Basedow's disease treated with thyroid antagonists: frequency of development of suppression 1 year after the initiation of the treatment].
    Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):424. PubMed ID: 4141673
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basedow's disease].
    Shizume K
    Naika; 1971 Jun; 27(6):1156-8. PubMed ID: 4103929
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current concepts in the treatment of Basedow's disease].
    Jaffiol C; Baldet L
    Sem Hop; 1975 Sep 10-20; 51(37-38):2265-7. PubMed ID: 56038
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pregnancy and Basedow's disease].
    Iino S; Watanabe T; Ban Y
    Nihon Rinsho; 1971 May; 29(5):1360-5. PubMed ID: 4103638
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of antithyroid drugs on the thyroid gland blood vessels in Basedow's disease].
    Yamasaki T
    Yonago Acta Med; 1966 Jul; 10(2):69-73. PubMed ID: 4167195
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid disease in pregnancy and the postpartum period.
    Davies TF; Cobin R
    Mt Sinai J Med; 1985 Jan; 52(1):59-77. PubMed ID: 2580233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Basedow's disease. 1. Drug therapy of hyperthyroidism].
    Tourniaire J
    Lyon Med; 1971; 18():Suppl:48-51. PubMed ID: 4105819
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basedow's disease].
    Kumahara Y
    Naika; 1965 Aug; 16(2):332-4. PubMed ID: 4161079
    [No Abstract]   [Full Text] [Related]  

  • 16. The challenge of treating Graves'-Basedow's disease patients with antithyroid drugs (ATD) in a large university hospital.
    Iacona A; Lima N; Perozim LM; Knobel M; Cavaliere H; Medeiros-Neto G
    Exp Clin Endocrinol; 1991 May; 97(2-3):297-302. PubMed ID: 1717299
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: T3 suppression test and TSH and prolactin reactions to TRH in patient with Basedow's disease under treatment with thyroid antagonists].
    Ikeda H; Imai Y; Uchimura H; Yamaji T; Matsuzaki S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):108. PubMed ID: 4141667
    [No Abstract]   [Full Text] [Related]  

  • 18. The evolution of the ophthalmopathy during antithyroid drug therapy and its relationship with serum thyroglobulin and antithyroglobulin antibody in patients with Basedow's disease.
    Bromberg N; Werner RS; Sgarbi JA; Werner MC; Romaldini JH
    Exp Clin Endocrinol; 1991 May; 97(2-3):354-7. PubMed ID: 1717300
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evolution of thyroximemia in the course of Basedow's disease treated with thyroid antagonists].
    Linquette M; Fossati P; Decoulx M; Racadot A; Benoit G; Asfour M
    Lille Med; 1977 Oct; 22(8):489-94. PubMed ID: 73116
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Basedow's disease].
    Bürgi H
    Rev Med Suisse Romande; 1975 May; 95(5):325-43. PubMed ID: 52173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.